ArticleBMC cancer2024

A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).

Mehmet Emin Buyukbayram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.